Emory University and other members of a research group have won a $23.7 million federal contract for vaccine research.
The National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health, will provide the funding.
Emory is part of a Vaccine and Treatment Evaluation Unit, or VTEU. The groups are to explore new vaccines and therapies for treatment of infectious diseases.
Subcontractors with Emory on the project include the Mayo Clinic, Kaiser Permanente Georgia, the University of Colorado and the Centers for Disease Control and Prevention.
"Emory’s strong basic and translational science programs within the Emory Vaccine Center and our infectious diseases programs in the Emory Children’s Center, combined with our track record in clinical trials and infectious diseases treatment and research in adults and children, presented a very strong portfolio to the NIH," says Mark Mulligan, a medical doctor and principal investigator of the Emory VTEU.
